HLA-B27 Misfolding in Spondyloarthropathy Pathogenesis
脊柱关节病发病机制中的 HLA-B27 错误折叠
基本信息
- 批准号:6534546
- 负责人:
- 金额:$ 37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-28 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Spondyloarthropathies are complex genetic diseases that frequently result in
chronic, progressive arthritis and ankylosis, and for which the cause and cure
remain unknown. HLA-1327 is a major predisposing factor in human disease, and
when expressed in rats can cause a spontaneous inflammatory disease resembling
human spondyloarthropathies. Despite considerable knowledge about the
physiological function of HLA-B27, the role of this molecule in the
pathogenesis of spondyloarthropathies remains unresolved. Recent results from
our laboratory have shown that HLA-B27 has an abnormal tendency to misfold.
This characteristic is dependent on structural features of HLA-1327 that
distinguish it from other HLA class I alleles, yet correlate strongly with the
arthritogenicity of several HLA-1327 subtypes. Protein misfolding has
significant biological effects, and in particular can cause an endoplasmic
reticulum (ER) stress response that activates several ER-to-nucleus signaling
pathways. This results in many alterations in gene expression, which in some
cells includes the induction of pro-inflammatory cytokines. We have developed a
novel hypothesis that takes into account several observations from human
studies and animal models, that HLA-1327 misfolding is the underlying basis for
its arthritogenicity. This proposal is designed to test this hypothesis using
an established transgenic rat model system. Specifically, in Aim I we will test
whether a non-disease associated HLA class I molecule that has been induced to
misfold by mutation can produce a phenocopy of spontaneous inflammatory disease
in rats. In parallel we will alter the peptide binding specificity of HLA-B27
without correcting misfolding, and determine whether it still causes disease.
In Aim 2 we will characterize changes in gene expression that result from
HLA-B27 misfolding in cells and tissues from transgenic rats prior to the
development of any clinical disease, using gene expression microarrays. Later
changes that provide a molecular fingerprint of the inflammatory process will
also be defined. In Aim 3 we will overexpress a key molecular sensor of ER
stress that can blunt the ER-to-nuclear signaling response, and determine
whether it prevents or ameliorates HLA-1327 induced spontaneous inflammatory
disease. These experiments will definitively test the misfolding hypothesis,
provide insights into the mechanisms responsible for spontaneous inflammatory
disease in rats, and may provide the basis for a novel therapeutic approach to
human spondyloarthropathies.
描述(由申请人提供):
脊椎关节病是复杂的遗传性疾病,经常导致
慢性进行性关节炎和关节强直,其原因和治疗
仍然未知。HLA-1327是人类疾病的主要诱发因素,
当在大鼠中表达时,可引起类似于
人类脊椎关节病尽管我们对
HLA-B27的生理功能,这种分子在
脊椎关节病的发病机制仍然没有解决。的最新结果
我们的实验室已经表明HLA-B27具有错误折叠的异常倾向。
这种特性取决于HLA-1327的结构特征,
将其与其他HLA I类等位基因区分开来,但与
几种HLA-1327亚型的致关节炎性。蛋白质错误折叠
显著的生物学效应,特别是可以引起内质网
内质网(ER)应激反应,激活几种ER到核的信号传导
途径。这导致基因表达的许多改变,在某些情况下,
细胞包括诱导促炎细胞因子。我们已经开发出一种
一个新的假设,考虑到几个观察,从人类
研究和动物模型,HLA-1327错误折叠是潜在的基础
它的关节炎性。本提案旨在检验这一假设,
建立了转基因大鼠模型体系。具体而言,在目标I中,我们将测试
是否已经诱导了非疾病相关的HLA I类分子,
突变引起的错误折叠可产生自发性炎症性疾病的表型
对大鼠同时,我们将改变HLA-B27的肽结合特异性,
而不纠正错误折叠,并确定它是否仍然会导致疾病。
在目标2中,我们将描述基因表达的变化,
HLA-B27在转基因大鼠细胞和组织中的错误折叠
任何临床疾病的发展,使用基因表达微阵列。后来
提供炎症过程分子指纹的变化将
也被定义。在目标3中,我们将过表达ER的关键分子传感器
应激可以钝化ER-到-核信号传导反应,并确定
是否预防或改善HLA-1327诱导的自发性炎症反应
疾病这些实验将最终验证错误折叠假说,
提供了对自发性炎症机制的见解,
疾病的大鼠,并可能提供一种新的治疗方法,
人类脊椎关节病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A. COLBERT其他文献
ROBERT A. COLBERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A. COLBERT', 18)}}的其他基金
Gene Expression Profiles in Paciarticular and Polyarticular Onset JRA
多关节型和多关节型 JRA 的基因表达谱
- 批准号:
7497408 - 财政年份:2007
- 资助金额:
$ 37万 - 项目类别:
Gene Expression Profiles & Pathogenic Mechanisms in Juvenile Spondyloarthropathie
基因表达谱
- 批准号:
7497419 - 财政年份:2007
- 资助金额:
$ 37万 - 项目类别:
HLA-B27 Misfolding in Spondyloarthropathy Pathogenesis
脊柱关节病发病机制中的 HLA-B27 错误折叠
- 批准号:
6794579 - 财政年份:2001
- 资助金额:
$ 37万 - 项目类别:
HLA-B27 Misfolding in Spondyloarthropathy Pathogenesis
脊柱关节病发病机制中的 HLA-B27 错误折叠
- 批准号:
6630373 - 财政年份:2001
- 资助金额:
$ 37万 - 项目类别:
HLA-B27 Misfolding in Spondyloarthropathy Pathogenesis
脊柱关节病发病机制中的 HLA-B27 错误折叠
- 批准号:
6932348 - 财政年份:2001
- 资助金额:
$ 37万 - 项目类别:
HLA-B27 Misfolding in Spondyloarthropathy Pathogenesis
脊柱关节病发病机制中的 HLA-B27 错误折叠
- 批准号:
6437975 - 财政年份:2001
- 资助金额:
$ 37万 - 项目类别:
MECHANISM AND CONSEQUENCES OF HLA-B 27 MISFOLDING
HLA-B 27 错误折叠的机制和后果
- 批准号:
6375231 - 财政年份:2000
- 资助金额:
$ 37万 - 项目类别:
MECHANISM AND CONSEQUENCES OF HLA-B 27 MISFOLDING
HLA-B 27 错误折叠的机制和后果
- 批准号:
6774087 - 财政年份:2000
- 资助金额:
$ 37万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 37万 - 项目类别:














{{item.name}}会员




